Great post petemantx! It doesn't matter to me if the damn stock price goes to .40 as I do not believe there is any relevance to the value of IPIX, it is just that we aren't quite there yet, 3 months is nothing compared to the years of waiting for stock's that I have owned. The share holders have a minimal risk of losing everything against the potential of a huge payoff. The short players have had their day soon it will be our turn.
3/17/2016 - Run-up started with +29% on ~900K volume ($1.56 closing price)
3/18/2016 - Run-up continued with +14% on ~600K volume (1.78 closing price)
5/24/2016 - Top-line result
I expect a similar run-up for B-OM. Last patient's visit should take place by the end of this month. I also expect the same for P Phase 2b. Last patient's visit should take place by year end. The question will be starting from what price (assuming positive B-OM result).
True longs care not why IPIX decided it was best not to release interim results. I am sure they have good reason and it has nothing to do with the trial results positive or negative. The science marches on, cannot wait for the next few months Pete. Strong buy and hold here.